Key facts
- Notable investors include Proxima Ventures (China), Hangzhou Oufang Venture Capital Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Shengxin Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Shengxin Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shengxin Medical
Developer of cardiovascular interventional medical devices intended for patients with heart failure. The company offers advanced research capabilities in balloon angioplasty, electrocardiographic integration, and platform-based interventional technologies, enabling healthcare professionals and medical institutions to address unmet clinical needs and deliver effective therapies for complex cardiovascular conditions in both hospital and specialized care settings.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Shengxin Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shengxin Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shengxin Medical in its N-PORT filings yet. We sweep new filings monthly.